Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity

Cell Growth and Differentiation

Volumn 7, Issue 2, 1996, Pages 173-178

  Gulti, Laith F ^a   Palmer, Kenneth C ^a   Chen, Yong Q ^a   Reddy, Kaladhar B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY;

ANTIBODY SPECIFICITY; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; HUMANS; NITRILES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TYRPHOSTINS;

EID: 0030030063     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull., 47: 87-98, 1991.
2. Carpenter, G., King, L., Jr., and Cohen, S. Rapid enhancement of protein phosphorylation in A431 cell membrane preparations by epidermal growth factor. J. Biol. Chem., 254: 4884-4891, 1979.
3. Gill, G. N., Buss, J. E, Lazar, C. S , Lifshitz, A., and Cooper, J. A Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells. J. Cell. Biochem., 19: 249-257, 1982
4. Carpenter, G., and Cohen, S. Epidermal growth factor. Annu. Rev Biochem., 43: 193-216, 1979.
5. Gill, G. N., and Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (Lond.), 293: 305-307, 1981.
6. Barnes, D. W. Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell Biol., 93: 1-4, 1982.
7. Schonbrunn, A., Krasnoff, M., Westendorf, J. M., and Tashjian, A. H., Jr. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. J. Cell Biol., 85: 786-788, 1980.
8. Armstrong, D. K., Isaacs, J. T., Ottaviano, Y. L., and Davidson, N. E. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res., 52: 3418-3424, 1992.
9. Filmus, J., Pollak, M. N., Cailleau, R., and Buick, R. N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and its growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-890, 1985.
10. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activity. Nature (Lond.), 284: 555-556, 1980.
11. Steller, H. Mechanisms and genes of cellular suicide. Science (Washington DC), 267: 1445-1449, 1995.
12. Thomas, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
13. Carpenter, G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem., 56: 881-914, 1987.
14. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
15. Reddy, K. B., Mangold, G. L., Tandon, A. K., Yoneda, T., Mundy, G. R., Zilberstein A., and Osborne, C. K. Inhibition of breast cancer cell growth in vitro by tyrosine kinase inhibitor. Cancer Res., 52: 3636-3641, 1992.
16. 1. Proc. Natl. Acad. Sci. USA, 89: 6683-6687, 1992.
17. Uckun, F. M., Tuel-Ahlgren, L., Song, C. W., Waddick, K., Myers, D. E., Kinhara, J., Ledbetter, J. A., and Schieven, G. L. Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proc. Natl. Acad. Sci. USA, 89: 9005-9009, 1992.
18. Sunada, H., Magun, B. E., Mendelson, J., and MacLeod, C. L. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc. Natl. Acad. Sci. USA, 83: 3825-3829, 1986.
19. Yaish, P., Gazit, A., Gilon, C., and Levitzki, A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science (Washington, DC), 242: 933-935, 1988.
20. Lyall, R. M., Zilberstein, A., Gazit, A., Gilon, C., Levitzki, A., and Schlessinger, J. Tyrophostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J. Biol Chem., 264: 14503-14509, 1989.
21. Yoneda, T., Lyall, R. M., Alsina, M. M., Persons, P. E., Spada, A. P., Levitzki, A., Zilberstein, A., and Mundy, G. R. The antiproliferative effects of tyrosine kinase inhibitor tyrphostin on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res., 51: 4430-4435, 1991.
22. French, L. E., Wohlwend, A., Sappino, A. P , Tschopp, J., and Schifferli, J. A. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest., 93: 877-884, 1994.
23. Quantin, B., and Breathnach, R. Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature (Lond), 344: 538-539, 1988.
24. Wilding, G., Lippman, M. E , and Gelman, E. P. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res., 48: 802-805, 1988.
25. Curran, T., Bravo, R., and Muller, R. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Cancer Surv., 4: 655-681, 1985.
26. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role of c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science (Washington, DC), 257: 212-214, 1992
27. Collins, M. K. L., and Rivas, A. L. The control of apoptosis in mammalian cells. Trends Biochem. Sci., 18: 307-309, 1993.
28. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (Lond.), 359: 552-554, 1992.
29. Hermeking, H., and Eick, D. Mediation of c-myc-induced apoptosis by p53. Science (Washington, DC), 265: 2091-2093, 1994.
30. Armstrong, D. K., Kaufmann, S. H., Ottaviano, Y. L., Furuya, Y., Buckley, J. A., Isaacs, J. T., and Davidson, N. E. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res., 54: 5280-5283, 1994.
31. Kwok, T. T., Mok, C. H., and Menton-Brennan, L. Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells Cancer Res., 54: 2834-2836, 1994.
32. Park, D. J., Nakamura, H., Chumakov, A. M., Said, J. W., Miller, C. W., Chen, D. L., and Koeffler, H. P. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene, 7: 1899-1906, 1994.
33. Wyllie, A. H. Apoptosis. Br. J. Cancer, 67: 205-208, 1993.
34. Hirata, Y., Moore, G. W., Bertagna, C., and Orth, D. N. Plasma concentration of immunoreactive human epidermal growth factor (urogastrone) in man. J. Clin. Endocrinol. Metab , 40: 440-444, 1980.
35. Hirata, Y., and Orth, D. N. Epidermal growth factor (urogastrone) in human tissues. J. Clin. Endocrinol. Metab., 48: 667-671, 1979.
36. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
37. Reddy, K. B., Yee, D., Coffey, R J., Hilsenbeck, S. G., and Osborne, C. K. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor α expression. Cell Growth & Differ., 5: 1275-1282, 1994.
38. Thomas, P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA, 77: 5202-5205, 1980.